{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:57:26Z","timestamp":1770919046502,"version":"3.50.1"},"reference-count":57,"publisher":"Begell House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>The relationship between human papillomavirus (HPV) and immune cells is vital for understanding the pathophysiology of infection and its role in neoplastic progression. High-risk human papillomavirus (HR-HPV) is the main cause of cervical cancer (CC). Thus, the association between immune response cells, the virus, and its behavior according to cervical disease development could provide new ways for understanding the entire process. Since the role and the presence of the immune response cells in the uterus cervix considering HPV infection has not been elucidated so far, this study aimed to identify the immune cells involved in high-grade intraepithelial lesions (HSIL) and CC development related to uterine cervical infection caused by HR-HPV. The study population included women who had positive molecular tests for HPV. Through the databases MEDLINE, EMBASE, LILACS, Cochrane, Scopus, Web of Science, CINAHL, Science Direct, and Google Scholar we identified 6,698 studies at the beginning. After the systematic review steps, the final number of included studies was 22. Cervical lesions were distributed according to the severity of lesions in HSIL, low-grade squamous intraepithelial lesions (LSIL), and negative for intraepithelial lesions or malignancy (NILM). The cellular phenotypes presented in these publications were T lymphocytes (LT), regulatory T lymphocytes (Tregs), macrophages (M&amp;#216;), natural killer cells (NK), natural killer T cells (NKT), Langerhans cells (LC), and dendritic cells (DC). Among the observed associations with cervical lesions and HR-HPV, we highlight the DC\/LC and M&amp;#216; being 36.4&amp;#37; of the cell types, followed by Tregs (31.8&amp;#37;) and LT CD4 \/ CD8 with 27.3&amp;#37;. The increased findings in innate and adaptive immunological response may imply both are acting together, with the innate response cells and Tregs being the most prominent. Since these cells have great importance in the maintenance and balance of the immunological system, the present study highlights the essential role of M&amp;#216; and Treg cells in the process of cervical lesion severity associated with HPV, suggesting that they may be focused as prognostic markers and immunotherapeutic targets.\n<\/p>","DOI":"10.1615\/critrevimmunol.2025057517","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T20:50:46Z","timestamp":1742331046000},"page":"33-49","source":"Crossref","is-referenced-by-count":1,"title":["Cellular Immune Response to High-Risk Human Papillomavirus Infection: A Systematic Review"],"prefix":"10.1615","volume":"45","author":[{"given":"Danielle Oliveira","family":"da Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Antonio Moreira","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa T.","family":"Gubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica Freire de Vasconcelos","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Marcon","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxlainy","family":"Tosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Vidotti","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas Aparecida","family":"Tozetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40:602-8.","DOI":"10.1080\/01443615.2019.1634030"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Kombe AJK, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2021;8:1-19.","DOI":"10.3389\/fpubh.2020.552028"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: Past, present, and future. Sex Med Rev. 2020;8:28-37.","DOI":"10.1016\/j.sxmr.2019.09.005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: A systematic review and network meta-analysis. BJOG. 2020;127:171-80.","DOI":"10.1111\/1471-0528.15854"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Walch-Ruckheim B, Stroder R, Theobald L, Pahne-Zeppenfeld J, Hegde S, Kim YJ, Bohle RM, Juhasz-Boss I, Solomayer EF, Smola S. Cervical cancer-instructed stromal fibroblasts enhance IL23 expression in dendritic cells to support expansion of Th17 cells. Cancer Res. 2019;79:1573-86.","DOI":"10.1158\/0008-5472.CAN-18-1913"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Zhou C, Tuong ZK, Frazer IH. Papillomavirus immune evasion strategies target the infected cell and the local immune system. Front Oncol. 2019;9.","DOI":"10.3389\/fonc.2019.00682"},{"key":"8","unstructured":"da Fonseca DO. Tipos celulares envolvidos na resposta imune a infeccao da cervice uterina por papilomavirus de alto risco oncogenico (hr-hpv) [dissertation]. Campo Grande (MS): Federal University of Mato Grosso do Sul; 2022."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.","DOI":"10.1007\/s10654-010-9491-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, Mc-Donald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372.","DOI":"10.1136\/bmj.n71"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Jimenez-Flores R, Mendez-Cruz R, Ojeda-Ortiz J, Munoz-Molina R, Balderas-Carrillo O, De La Luz Diaz-Soberanes M, Lebecque S, Saeland S, Daneri-Navarro A, Garcia-Carranca A, Ullrich SE, Flores-Romo L. Highrisk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology. 2006;117:220-8.","DOI":"10.1111\/j.1365-2567.2005.02282.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Al-Saleh W, Delvenne P, Arrese JE, Boniver J, Nikkels AF, Pierard GE. Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage\/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch. 1995;427:41-8.","DOI":"10.1007\/BF00203736"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Connor JP, Ferrer K, Kane JP, Goldberg JM. Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia. Gynecol Oncol. 1999;75:130-5.","DOI":"10.1006\/gyno.1999.5559"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Viac J, Guerin-Reverchoni I, Chardonnet Y, Bremond A. Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: Correlation with human papillomavirus infection. Immunobiology. 1990;180:328-38.","DOI":"10.1016\/S0171-2985(11)80296-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Al-Saleh W, Giannini SL, Jacobs N, Moutschen M, Doyen J, Boniver J, Delvenne P. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol. 1998;184:283-90.","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<283::AID-PATH25>3.0.CO;2-K"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The host-microbe interplay in human papillomavirus-induced carcinogenesis. Microorganisms. 2019;7:1-22.","DOI":"10.3390\/microorganisms7070199"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Westrich JA, Warren CJ, Pyeon D. Evasion of host immune defenses by human papillomavirus. Virus Res. 2017;231:21-33.","DOI":"10.1016\/j.virusres.2016.11.023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Prata TTM, Bonin CM, Ferreira AMT, Padovani CTJ, Fernandes CE dos S, Machado AP, Tozetti IA. Local immunosuppression induced by high viral load of human papillomavirus: Characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology. 2015;146:113-21.","DOI":"10.1111\/imm.12487"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kobayashi A, Weinberg V, Darragh T, Smith-McCune K. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008;1:412-20.","DOI":"10.1038\/mi.2008.33"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Cassandri F, Tozetti IA, Fernandes CE dos S, Almeida FG de, Falc\u00e3o GR, Scapulatempo IDL, Prata TTM, Padovani CTJ, Alves DB, Ferreira AT, Abdo MAGS. S100, CD68, and MHC class II molecule expression in cervical high- and low-grade HPV-induced lesions. Rev Soc Bras Med Trop. 2012;45:3-8.","DOI":"10.1590\/S0037-86822012000100002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Davidson B, Goldberg I, Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol Res Pract. 1997;193:491-5.","DOI":"10.1016\/S0344-0338(97)80102-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Mazibrada J, Ritt\u00e0 M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, Ciotti M, Orlando A, Surico N, Chiusa L, Landolfo S, Gariglio M. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol. 2008;108:112-20.","DOI":"10.1016\/j.ygyno.2007.08.095"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Swangphon P, Pientong C, Sunthamala N, Bumrungthai S, Azuma M, Kleebkaow P, Tangsiriwatthana T, Sangkomkamhang U, Kongyingyoes B, Ekalaksananan T. Correlation of circulating CD64+\/CD163+ monocyte ratio and stroma\/peri-tumoral CD163+ monocyte density with human papillomavirus infected cervical lesion severity. Cancer Microenviron. 2017;10:77-85.","DOI":"10.1007\/s12307-017-0200-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, Syrjanen KJ, Cunha-Filho JS. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression\u00e2\u0080\u0094clinicopathological correlation. Gynecol Oncol. 2007;105:157-65.","DOI":"10.1016\/j.ygyno.2006.11.023"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Muntinga CLP, de Vos van Steenwijk PJ, Bekkers RLM, van Esch EMG. Importance of the immune microenvironment in the spontaneous regression of cervical squamous intraepithelial lesions (cSIL) and implications for immunotherapy. J Clin Med. 2022;11.","DOI":"10.3390\/jcm11051432"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Zhang J, Jin S, Li X, Liu L, Xi L, Wang F, Zhang S. Human papillomavirus type 16 disables the increased natural killer cells in early lesions of the cervix. J Immunol Res. 2019:1-8.","DOI":"10.1155\/2019\/9182979"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Alves DB, Tozetti IA, Gatto FA, Cassandri F, Ferreira AMT, Carlos Eurico dos Santos F, Falc\u00e3o GR, Scapulatempo IDL, Padovani CTJ, Abdo MAGS. Linf\u00f3citos CD4, CD8 e c\u00e9lulas NK no estroma da c\u00e9rvice uterina de mulheres infectadas pelo papilomavirus humano. Rev Soc Bras Med Trop. 2010;43:425-9.","DOI":"10.1590\/S0037-86822010000400018"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Hu T, Yang P, Zhu H, Chen X, Xie X, Yang M, Liu S, Wang H. Accumulation of invariant NKT cells with increased IFN-\u03b3 production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia. Diagn Pathol. 2015;10:1-10.","DOI":"10.1186\/s13000-015-0254-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Adurthi S, Krishna S, Mukherjee G, Bafna UD, Devi U, Jayshree RS. Regulatory T cells in a spectrum of HPV-induced cervical lesions: Cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol. 2008;60:55-65.","DOI":"10.1111\/j.1600-0897.2008.00590.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Bedoya AM, Jaramillo R, Baena A, Castano J, Olaya N, Zea AH, Herrero R, Sanchez GI. Location and density of immune cells in precursor lesions and cervical cancer. Cancer Microenviron. 2013;6:69-77.","DOI":"10.1007\/s12307-012-0097-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Bonin CM, Padovani CTJ, Ferreira AMT, Avila LS, MacHado AP, Prata TTM, Fernandes CES, Tozetti IA. Predominant overexpression of CD25\/FOXP3, IFN-\u00ce\u00b3, and suppressive cytokines in high-grade lesion samples infected with human papillomavirus. J Bras Patol Med Lab. 2017;53:53-60.","DOI":"10.5935\/1676-2444.20170004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Bonin CM, Padovani CTJ, da Costa IP, \u00c1vila LS, Ferreira AMT, Fernandes CES, dos Santos AR, Tozetti IA. Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection. J Med Virol. 2019;91:317-25.","DOI":"10.1002\/jmv.25312"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Vattai A, Kremer N, Meister S, Beyer S, Keilmann L, Buschmann C, Corradini S, Schmoeckel E, Kessler M, Mahner S, Jeschke U, Hertlein L, Kolben T. Increase of the T\u00e2\u0080\u0091reg\u00e2\u0080\u0091recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia. J Cancer Res Clin Oncol. 2023;149:6613-23.","DOI":"10.1007\/s00432-023-04638-w"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Maskey N, Thapa N, Maharjan M, Shrestha G, Maharjan N, Cai H, Liu S. Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu. Cancer Manag Res. 2019;11:7647-55.","DOI":"10.2147\/CMAR.S217264"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, Capilna M, F\u00e9lix S, Seilles E, Mougin C, Pretet JL. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol. 2006;102:22-31.","DOI":"10.1016\/j.ygyno.2005.11.039"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Hibma MH. The immune response to papillomavirus during infection persistence and regression. Open Virol J. 2013;6:241-8.","DOI":"10.2174\/1874357901206010241"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Manzo-Merino J, Toro-Arreola SD, Rocha-Zavaleta L, Peralta-Zaragoza O, Jimenez-Lima R, Madrid-Marina V. Immunology of cervical cancer. Revista Investig Clin. 2020;72(4):188-97.","DOI":"10.24875\/RIC.20000057"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Song D, Li H, Li H, Dai J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer (review). Oncol Lett. 2015;10:600-6.","DOI":"10.3892\/ol.2015.3295"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Ntuli L, Mtshali A, Mzobe G, Liebenberg LJP. Role of immunity and vaginal microbiome in clearance and persistence of human papillomavirus infection. Front Cellular Infection Microbiol. 2022;12:1-10.","DOI":"10.3389\/fcimb.2022.927131"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Bashaw AA, Leggatt GR, Chandra J, Tuong ZK, Frazer IH. Modulation of antigen presenting cell functions during chronic HPV infection. Papillomavirus Res. 2017;4: 58-65.","DOI":"10.1016\/j.pvr.2017.08.002"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Wang Y, He M, Zhang G, Cao K, Yang M, Zhang H, Liu H. The immune landscape during the tumorigenesis of cervical cancer. Cancer Med. 2021;10:2380-95.","DOI":"10.1002\/cam4.3833"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Lendeckel U, Venz S, Wolke C. Macrophages: Shapes and functions. ChemTexts. 2022;8:1-12.","DOI":"10.1007\/s40828-022-00163-4"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Liu Y, Li L, Li Y, Zhao X. Inflammation in cervical cancer. Biomedicines. 2020:1-6.","DOI":"10.1155\/2020\/6842963"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Loureiro JP, Cruz MS, Cardoso AP, Oliveira MJ, Macedo MF. Human iNKT cells modulate macrophage survival and phenotype. Biomedicines. 2022;10.","DOI":"10.3390\/biomedicines10071723"},{"key":"45","unstructured":"Abbas AK, Lichtman AH, Pillai S. Imunologia Celular e Molecular - Traducao da 8a. edicao. Sao Paulo, Brazil: Elsevier; 2015."},{"key":"46","doi-asserted-by":"crossref","unstructured":"Piersma SJ. Immunosuppressive tumor microenvironment in cervical cancer patients. Cancer Microenviron. 2011;4:361-75.","DOI":"10.1007\/s12307-011-0066-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Paluskievicz CM, Cao X, Abdi R, Zheng P, Liu Y, Bromberg JS. T regulatory cells and priming the suppressive tumor microenvironment. Front Immunol. 2019;10:1-15.","DOI":"10.3389\/fimmu.2019.02453"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Litwin TR, Irvin SR, Chornock RL, Sahasrabuddhe VV, Stanley M, Wentzensen N. Infiltrating T-cell markers in cervical carcinogenesis: A systematic review and meta-analysis. Br J Cancer. 2021;124:831-41.","DOI":"10.1038\/s41416-020-01184-x"},{"key":"49","unstructured":"Das D, Sarkar B, Mukhopadhyay S, Banerjee C, Mondal SB. An altered ratio of CD4+ And CD8+ T lymphocytes in cervical cancer tissues and peripheral blood-a prognostic clue? Asian Pacific J Cancer Prev. 2018;19:471-8."},{"key":"50","doi-asserted-by":"crossref","unstructured":"Wu Y, Ye S, Goswami S, Pei X, Xiang L, Zhang X, Yang H. Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients. BMC Cancer. 2020;20:1-12.","DOI":"10.1186\/s12885-020-6633-x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Kousar K, Ahmad T, Naseer F, Kakar S, Anjum S. Immune landscape and immunotherapy options in cervical carcinoma. Cancers. 2022;14(18):4458.","DOI":"10.3390\/cancers14184458"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Lakomy DS, Wu J, Lombe D, Papasavvas E, Citonje S, Yimin M, Luis G, Elizabeth JM, Lin LL. Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review. Cancer Med. 2021:4206-20.","DOI":"10.1002\/cam4.4017"},{"key":"53","unstructured":"Shiri P, Shirvaliloo M, Khalo A, Kasho A. International immunopharmacology cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis? Int Immunopharmacol. 2022:1-8."},{"key":"54","doi-asserted-by":"crossref","unstructured":"Hayati AR. An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia. Int J Gynecol Pathol. 2006;3:83-8.","DOI":"10.1097\/01.pgp.0000225850.90115.bc"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Berti FCB, Pereira APL, Cebinelli GCM, Trugilo KP, Braj\u00c3\u00a3o de Oliveira K. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma. Cytokine Growth Factor Rev. 2017;34:1-13.","DOI":"10.1016\/j.cytogfr.2017.03.002"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Gutierrez-Hoya A, Soto-Cruz I. NK cell regulation in cervical cancer and strategies for immunotherapy. Cells. 2021;10.","DOI":"10.3390\/cells10113104"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Cao G, Yue J, Ruan Y, Han Y, Zhi Y, Lu J, Liu M, Xu X, Wang J, Gu Q, Wen X, Gao J, Zhang Q, Kang J, Wang C, Li F. Single-cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment. EMBO J. 2023;42(16):e110757.","DOI":"10.15252\/embj.2022110757"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Ao C, Zeng K. The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer. Infect Genet Evol. 2018;65:406-13.","DOI":"10.1016\/j.meegid.2018.08.014"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/4ce3371b31d0725c\/CRI-57517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T05:42:41Z","timestamp":1750657361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,3e5b3af60141eb55,4ce3371b31d0725c.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2025057517","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}